NDC 25021-305

chlorothiazide sodium

Chlorothiazide Sodium

chlorothiazide sodium is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Chlorothiazide Sodium.

Product ID25021-305_b3297614-fada-4119-86c9-8701a446f6c1
NDC25021-305
Product TypeHuman Prescription Drug
Proprietary Namechlorothiazide sodium
Generic NameChlorothiazide Sodium
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2015-10-12
Marketing CategoryANDA / ANDA
Application NumberANDA202462
Labeler NameSagent Pharmaceuticals
Substance NameCHLOROTHIAZIDE SODIUM
Active Ingredient Strength500 mg/18mL
Pharm ClassesIncreased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 25021-305-20

1 VIAL in 1 CARTON (25021-305-20) > 18 mL in 1 VIAL
Marketing Start Date2015-10-12
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
CHLOROTHIAZIDE SODIUM500 mg/18mL

OpenFDA Data

SPL SET ID:377dc515-e381-4196-8bc7-b738606c57ac
Manufacturer:Sagent Pharmaceuticals
UNII
RxNorm Concept Unique ID - RxCUI
  • 484152
  • Pharmacological Class

    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "chlorothiazide sodium" or generic name "Chlorothiazide Sodium"

    NDCBrand NameGeneric Name
    63323-658ChlorothiazideCHLOROTHIAZIDE SODIUM
    0517-1820Chlorothiazide SodiumChlorothiazide Sodium
    17478-419Chlorothiazide SodiumChlorothiazide Sodium
    25021-305chlorothiazide sodiumchlorothiazide sodium
    67457-263chlorothiazide sodiumchlorothiazide sodium
    47335-330CHLOROTHIAZIDE SODIUMCHLOROTHIAZIDE SODIUM
    76478-711Sodium Diurilchlorothiazide sodium

    © 2020 FDA.report
    This site is not affiliated with or endorsed by the FDA.